Conformational Dynamics of the Flexible Catalytic Loop inMycobacterium tuberculosis1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase
- 18 December 2008
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 73 (1), 26-38
- https://doi.org/10.1111/j.1747-0285.2008.00749.x
Abstract
In mycobacteria, the biosynthesis of the precursors to the essential isoprenoids, isopentenyl diphosphate and dimethylallyl pyrophosphate is carried out by the methylerythritol phosphate pathway. This route of synthesis is absent in humans, who utilize the alternative mevalonate acid route, thus making the enzymes of the methylerythritol phosphate pathway of chemotherapeutic interest. One such identified target is the second enzyme of the pathway, 1‐deoxy‐d‐xylulose 5‐phosphate reductoisomerase. Only limited information is currently available concerning the catalytic mechanism and structural dynamics of this enzyme, and only recently has a crystal structure of Mycobacterium tuberculosis species of this enzyme been resolved including all factors required for binding. Here, the dynamics of the enzyme is studied in complex with NADPH, Mn2+, in the presence and absence of the fosmidomycin inhibitor using conventional molecular dynamics and an enhanced sampling technique, reversible digitally filtered molecular dynamics. The simulations reveal significant differences in the conformational dynamics of the vital catalytic loop between the inhibitor‐free and inhibitor‐bound enzyme complexes and highlight the contributions of conserved residues in this region. The substantial fluctuations observed suggest that 1‐deoxy‐D‐xylulose 5‐phosphate reductoisomerase may be a promising target for computer‐aided drug discovery through the relaxed complex method.Keywords
This publication has 55 references indexed in Scilit:
- Drug Resistance in TuberculosisJournal of Tropical Pediatrics, 2007
- Anti-Cancer Therapy: Targeting the Mevalonate PathwayCurrent Cancer Drug Targets, 2006
- Mevalonate and Nonmevalonate Pathways for the Biosynthesis of Isoprene UnitsBioscience, Biotechnology, and Biochemistry, 2002
- The non-mevalonate pathway of isoprenoids: genes, enzymes and intermediatesCurrent Opinion in Chemical Biology, 2001
- Isoprenoid biosynthesis: The evolution of two ancient and distinct pathways across genomesProceedings of the National Academy of Sciences, 2000
- The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathwaysMolecular Microbiology, 2000
- Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial DrugsScience, 1999
- A family of transketolases that directs isoprenoid biosynthesis via a mevalonate-independent pathwayProceedings of the National Academy of Sciences, 1998
- Creating Isoprenoid DiversityScience, 1997
- Biochemistry of Polyisoprenoid BiosynthesisAnnual Review of Biochemistry, 1976